To Get Full Access :

Xdemvy

Xdemvy is an eye drop treatment that targets and kills Demodex mites to treat blepharitis (eyelid inflammation). Apply twice daily for six weeks to clear up symptoms.

The information outlined in the molecule details section below would help you evaluate Para IV filing opportunities early to secure a first-to-file advantage.

Molecule Details :

  • Molecule Name :

    Lotilaner
  • Innovator :

    TARSUS PHARMACEUTICALS INC
  • Approval Date :

    25-Jul-23
  • NCE-1 Date :

    25-Jul-27
  • NCE Date :

    25-Jul-28
  • Dosage Form :

    Ophthalmic Drops
  • Strength :

    0.25%
  • Therapeutic Category :

    Antiparasitic
  • Revenue ($M) :

    180

Year-wise Projected Sales ($M) :

  • 2025 :

    337
  • 2026 :

    485
  • 2027 :

    668
  • 2028 :

    789
  • 2029 :

    920
  • 2030 :

    1,049
  • 2031 :

    1,209
Looking for this molecule for your next clinical research? Access regulatory-compliant comparators with assured timelines—delivered reliably through our global network.

Why Partner With Us

Login With

For full access Sign-up / Sign-in using below Methods:

By continuing, you agree to our Terms & Conditions and Privacy Policy. You can review them anytime.

Are you sure want to logout from NCE Grid?